Navigation Links
Australia to Show Leniency towards U.S. Pharmaceutical Companies

Australian would remove the amendment which states to reduce the price of the drug obtained from US.

The Trade Minister and the // acting Prime Minister Mark Vaile reported that this amendment was accepted because it was supported by the major opposition party in Australia (Labor Party).

The reason that the party supported the amendment was to prevent the delay in the introduction of new generic drugs.

According to the amendment the Australian authorities have the power to levy heavy fines and ask the pharmaceutical company to reimburse for the lost sales.

Apart from that the company has to pay extra cash to the federal and state government. This amendment became a law and was in function from the first of January 2005.

But the Australian government also considers the risks the pharmaceutical company has to face and has told that this act would be reviewed.

The government told the companies that the act would be removed if the companies proved that the act has been misused by the Australian government.

But still the Australian government still wishes that both the parties discuss on this issue and come out with a better law which would not be detrimental to both the Australian government and the pharmaceutical companies.

He also mentioned that the pharmaceutical companies can delay their patents only if there is an enhancement in the profits due to the drug.

But the government will never allow the misuse of the law at any cost.


'"/>




Page: 1

Related medicine news :

1. Australian Scientists Silence Cancer Gene
2. Australia earmarks $74 Million to Fight Bird Flu
3. Australian Government To Stockpile Anti-Bird Flu Drug Relenza
4. Obesity among The Poor in Australia.
5. Increase In Health Insurance Premium Likely In Australia
6. Australian Company Gets $10 million For Developing Skin Cancer Gel
7. Australian Health funds stand accused
8. Bird flu scare in Australia
9. Australia awaits US FDA reports on ADHD drugs
10. No booster vaccine For every fourth child in Australia
11. Australia Witnesses A Fall In the Number of Organ Donors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/3/2016)... ... May 03, 2016 , ... ... is launching a new client service center in La Vergne, Tennessee, near Nashville. ... provide the full range of Empyrean client services. , “Our Nashville-area center allows ...
(Date:5/3/2016)... ... May 03, 2016 , ... Each year, about 800,000 people suffer from ... the United States and account for one death every four minutes. Many people ... disabled. HCR ManorCare is launching a video series called “Your Brain,” in conjunction with ...
(Date:5/3/2016)... Indianapolis, IN (PRWEB) , ... May 03, 2016 ... ... employee benefits advisory organization, announces Benefits Alliance Insurance Services as the latest addition ... powerhouse Southern California-based Firm comprised of Partners Wayne Blasman, David Styles, and Paul ...
(Date:5/3/2016)... ... May 03, 2016 , ... Octo ... solutions and digital consulting services to the federal government, has been awarded a ... / Indefinite Quantity (ID/IQ) contract in support of the U.S. Army Program Executive ...
(Date:5/3/2016)... ... May 03, 2016 , ... AvePoint, ... release of DocAve 6 Service Pack (SP) 7, the enterprise-class infrastructure ... 2016 and take advantage of the platform’s latest features – whether in an ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... May 2, 2016 Kalorama Information noted the ... Records) market in a recent white paper.  The healthcare ... physician usage, a growing market are among the top ... Kalorama,s report EMR 2016: The Market for ... seventh complete study of the EMR industry, and the ...
(Date:5/2/2016)... , May 2, 2016  Deerfield announced ... financing of Graybug Vision, Inc. Graybug Vision is ... therapies that may transform care for ocular diseases ... Graybug Vision,s technology was first developed at Johns ... a startup venture. Graybug Vision ...
(Date:5/2/2016)... , May 2, 2016  Celsion Corporation (NASDAQ: ... today announced data from the first cohort of ... trial (the OVATION Study) combining GEN-1, the Company,s ... the treatment of newly-diagnosed patients with advanced ovarian ... interval debulking surgery.  In the first three patients ...
Breaking Medicine Technology: